← Back
$KNSA All transactions

Kiniksa Pharmaceuticals International, plc

M 10b5-1 Plan

$ Value

$0

Shares

18,299

Price

$0

Filed

Jun 5

Insider

Name

Ragosa Mark

Title

CHIEF FINANCIAL OFFICER

CIK

0001835458

Roles

Officer

Transaction Details

Transaction Date

2025-06-03

Code

M

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

Footnotes

This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on September 3, 2024. | The option is fully vested and exercisable.

Filing Info

Accession No.

0001415889-25-015778

Form Type

4

Issuer CIK

0001730430

Ragosa Mark's History

Date Ticker Type Value
2026-04-07 KNSA M
2026-04-07 KNSA F $64K
2026-04-07 KNSA M $0
2026-04-01 KNSA M
2026-04-01 KNSA F $121K
2026-04-01 KNSA A $0
2026-04-01 KNSA A $0
2026-04-01 KNSA A $0
2026-04-01 KNSA M $0
2026-04-01 KNSA M $0

Other Insiders at KNSA (90d)

Insider Bought Sold Last
Quart Barry D $1.1M 2026-04-06
Levy Richard S 2026-02-01
Megna Michael R
CHIEF ACCOUNTING OFFICER
$309K 2026-04-09
Patel Sanj K
CHAIRMAN & CEO
$364K 2026-04-07
Paolini John F.
CHIEF MEDICAL OFFICER
2026-04-07
Ragosa Mark
CHIEF FINANCIAL OFFICER
2026-04-07
Moat Ross
CHIEF OPERATING OFFICER
$195K 2026-04-09
Tessari Eben
CHIEF STRATEGY OFFICER
2026-04-07